Independence Bank of Kentucky’s Zimmer Biomet ZBH Stock Holding History

Independence Bank of Kentucky’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.7K	Sell	252 -976	-79%	-$85.6K	﹤0.01%	461
2026 Q1	$111K	Sell	1,228 -405	-25%	-$37.2K	0.01%	338
2025 Q4	$147K	Buy	1,633 +145	+10%	+$13.7K	0.02%	315
2025 Q3	$147K	Sell	1,488 -553	-27%	-$54.8K	0.02%	318
2025 Q2	$186K	Sell	2,041 -586	-22%	-$56.7K	0.03%	288
2025 Q1	$297K	Sell	2,627 -586	-18%	-$62.7K	0.05%	241
2024 Q4	$339K	Sell	3,213 -1,141	-26%	-$122K	0.05%	236
2024 Q3	$470K	Sell	4,354 -1,289	-23%	-$141K	0.1%	181
2024 Q2	$612K	Sell	5,643 -2,442	-30%	-$288K	0.16%	136
2024 Q1	$1.07M	Sell	8,085 -79	-1%	-$9.87K	0.32%	87
2023 Q4	$994K	Sell	8,164 -1,740	-18%	-$194K	0.35%	76
2023 Q3	$1.11M	Sell	9,904 -418	-4%	-$53.1K	0.47%	62
2023 Q2	$1.5M	Sell	10,322 -2,058	-17%	-$280K	0.61%	49
2023 Q1	$1.6M	Sell	12,380 -515	-4%	-$64.7K	0.7%	44
2022 Q4	$1.64M	Sell	12,895 -810	-6%	-$94K	0.74%	44
2022 Q3	$1.43M	Sell	13,705 -3,715	-21%	-$408K	0.71%	47
2022 Q2	$1.83M	Sell	17,420 -175	-1%	-$20.8K	0.82%	40
2022 Q1	$2.25M	Buy	17,595 +502	+3%	+$60.5K	0.89%	31
2021 Q4	$2.11M	Buy	17,093 +2,282	+15%	+$299K	0.86%	35
2021 Q3	$2.1M	Buy	14,811 +2,775	+23%	+$408K	0.91%	34
2021 Q2	$1.88M	Buy	12,036 +469	+4%	+$76K	0.83%	38
2021 Q1	$1.8M	Sell	11,567 -1,766	-13%	-$274K	0.87%	35
2020 Q4	$2M	Sell	13,333 -608	-4%	-$85.9K	1.03%	28
2020 Q3	$1.84M	Sell	13,941 -671	-5%	-$87.7K	1.05%	27
2020 Q2	$1.69M	Buy	14,612 +1,406	+11%	+$162K	1.1%	28
2020 Q1	$1.3M	Sell	13,206 -72	-0.5%	-$9.44K	1.02%	30
2019 Q4	$1.93M	Sell	13,278 -381	-3%	-$52.6K	1.25%	23
2019 Q3	$1.82M	Sell	13,659 -896	-6%	-$116K	1.3%	22
2019 Q2	$1.66M	Buy	14,555 +191	+1%	+$22.4K	1.3%	23
2019 Q1	$1.78M	Sell	14,364 -83	-0.6%	-$9.43K	1.46%	18
2018 Q4	$1.46M	Sell	14,447 -901	-6%	-$101K	1.32%	22
2018 Q3	$1.96M	Sell	15,348 -730	-5%	-$86.8K	1.54%	17
2018 Q2	$1.74M	Buy	16,078 +582	+4%	+$63.3K	1.46%	21
2018 Q1	$1.64M	Buy	15,496 +51	+0.3%	+$5.92K	1.4%	22
2017 Q4	$1.81M	Buy	+15,445	New	+$1.75M	1.55%	18

Other funds holding ZBH

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return

Independence Bank of Kentucky's ZBH Position: Q2 2026 in Review

Independence Bank of Kentucky reduced its Zimmer Biomet (ZBH) stake by 79% in Q2 2026, selling an estimated $85.6K and leaving 252 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Independence Bank of Kentucky first reported a position in ZBH in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.25M in Q1 2022. 453 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Independence Bank of Kentucky held 252 shares of Zimmer Biomet worth $21.7K as of Q2 2026.
Independence Bank of Kentucky sold 976 Zimmer Biomet shares in Q2 2026, an estimated $85.6K.
Zimmer Biomet made up ﹤0.01% of Independence Bank of Kentucky's portfolio in Q2 2026, its #461 holding.
Independence Bank of Kentucky first reported a position in Zimmer Biomet in Q4 2017 and has held it in 35 quarters since.
Independence Bank of Kentucky's Zimmer Biomet position peaked at $2.25M in Q1 2022.
453 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.